维普中文期刊产品整合服务
105篇 您的检索式:作者名="FALSINI G"
    题名 作者 年代 出处 被引量
1The clinical burden of contrast media-induced nephropatht显示文摘Liistro F Falsini G Bolognese L 0,,10:1
2The Clinical burden of contrast-media-induced nephropathy显示文摘Liistro F Falsini G Bolognese L 2003Ital Heart J2003,4,10:1
3Shifting from pharmacologicalto systematic mechanical reperfusion therapy for acute myocardial infarction via a cooperating network: Impact on reperfusion rate and in - hospital mortality显示文摘Falsini G Liistro F Ducci K 2008J Cardiovasc Med ( Hagerstown)2008,9,3:1
4Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions:the EVEREST trial显示文摘Bolognese L Falsini G Liistro F 2006J Am Coll Cardiol2006,47,3:1
5Impact of iso- osmolar versus low-osmolar contrast agents on contrast- induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction Trial) 显示文摘Bolognese L Falsini G Schwenke C 2012Am J Cardiol2012,09,1:1
6Randomized comparison of upstreamtirofiban versus downstream high bolus dose tirofiban or abciximab on tissuelevel perfusion and troponin release in high-risk acute coronary syndromes trea-ted with percutaneous coronary interventions:the EVEREST trial显示文摘Bolognese L Falsini G Liistro F 2006J AmColl Cardiol2006,47,3:1
7Eplcardial and microvascular reperfusion with primary percutaneous coronary intervention显示文摘BOLOGNESE L FALSINI G LIISTRO F 2005Ital Heart J2005,6,:1
8The clinical burden of contrast mediainduced nephropathy显示文摘Liistro F Falsini G Bolognese L 2003Ital Heart J2003,4,10:1
9Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions:the EVEREST trial 显示文摘BOLOGNESE L FALSINI G LRSTRO F 2006J Am Coll Cardiol2006,47,3:1
10The clinical burden of contrast media-inducenephropathy 显示文摘Liistro F Falsini G Bolognese L 2003Ital Heart J2003,4,10:1
11Randomized comparison of upstream tirofiban versus downstream high Bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions:the EV-EREST trial显示文摘 Falsini G Liistro F 2006J Am Coil Cardiol2006,47,3:1
12The clinical burden of contrast media-induced nephropathy显示文摘Liistro F Falsini G Bolognese L 2003Ital Heart J2003,4,10:1
13Impact of iso- osmolar versus low-osmolar contrast agents on contrast- induced nephropathy and tissue reperfusion in unselect- ed patients with ST-segment elevation myocardial in- farction undergoing primary percutaneous coronary inter- vention (from the contrast media and nephrotoxicity fol- lowing primaryangioplasty for acute myocardial infarction Trial)显示文摘Bolognese L Falsini G Schwenke C 2012Am J Cardiol2012,109,1:1
14The clinical burden of contrast media-induced nephropathy显示文摘Liistro F Falsini G Bolognese I 2003Ital Heart J2003,4,10:1
15Evaluation of upper-limb spasticity after stroke: A clinical and neurophysiologic study 显示文摘Pizzi A Carlucci G Falsini C 2005Arch Phys Med Rehabil2005,86,3:1
16The clinical burden of contrast media-induced nephropathy 显示文摘Liistro F Falsini G Bologness L 2003Hal Heart J2003,4,:1
17Randomized comparison of upstream tirofiban versus downstream high bolus does tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk actue coronary syndromes treated with percutaneous coronary interventions:The EVEREST Trial显示文摘Bolognese L Falsini G Liistro F 2006J Am Coll Cardiol2006,47,3:1
18Evaluation of upper-limb spasticity after stroke:A clinical and neurophysiologic study显示文摘Pizzi A Carlucci G Falsini C 2005Arch Phys Med Rehabil2005,86,3:1
19Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary inteventions: the EVEREST trial显示文摘BOLOGNESE L FALSINI G LIISTRO F 2006J Am Coll Cardiol2006,47,:1
20The clinical burden of contrast media - induced nephropathy 显示文摘LI1STRO F FALSINI G BOLOGNESE L 2003Ital Heart J2003,4,10:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费